Massachusetts Financial Services’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
644,530
-109,017
| -14% | -$3.44M | 0.01% | 614 |
|
|
2025
Q1 | $25M | Sell |
753,547
-76,073
| -9% | -$2.52M | 0.01% | 571 |
|
|
2024
Q4 | $28.5M | Buy |
829,620
+169,229
| +26% | +$5.82M | 0.01% | 550 |
|
|
2024
Q3 | $26.4M | Buy |
660,391
+140,690
| +27% | +$5.63M | 0.01% | 558 |
|
|
2024
Q2 | $15.7M | Buy |
519,701
+13,547
| +3% | +$409K | ﹤0.01% | 599 |
|
|
2024
Q1 | $17M | Sell |
506,154
-2,478
| -0.5% | -$83.2K | 0.01% | 592 |
|
|
2023
Q4 | $16.4M | Buy |
508,632
+434
| +0.1% | +$14K | 0.01% | 586 |
|
|
2023
Q3 | $16.7M | Buy |
508,198
+864
| +0.2% | +$28.3K | 0.01% | 580 |
|
|
2023
Q2 | $17.9M | Buy |
507,334
+96,397
| +23% | +$3.39M | 0.01% | 567 |
|
|
2023
Q1 | $13.4M | Buy |
410,937
+70,834
| +21% | +$2.31M | ﹤0.01% | 588 |
|
|
2022
Q4 | $18.7M | Sell |
340,103
-75,348
| -18% | -$4.15M | 0.01% | 555 |
|
|
2022
Q3 | $18.4M | Buy |
415,451
+28,539
| +7% | +$1.26M | 0.01% | 560 |
|
|
2022
Q2 | $18.9M | Sell |
386,912
-2,848
| -0.7% | -$139K | 0.01% | 563 |
|
|
2022
Q1 | $19M | Sell |
389,760
-170,108
| -30% | -$8.28M | 0.01% | 587 |
|
|
2021
Q4 | $23.9M | Sell |
559,868
-107,916
| -16% | -$4.6M | 0.01% | 590 |
|
|
2021
Q3 | $25.6M | Sell |
667,784
-8,836
| -1% | -$339K | 0.01% | 588 |
|
|
2021
Q2 | $19.1M | Buy |
676,620
+71,755
| +12% | +$2.03M | 0.01% | 620 |
|
|
2021
Q1 | $20M | Buy |
604,865
+91,295
| +18% | +$3.02M | 0.01% | 604 |
|
|
2020
Q4 | $18.6M | Buy |
513,570
+183,902
| +56% | +$6.65M | 0.01% | 598 |
|
|
2020
Q3 | $11.2M | Buy |
+329,668
| New | +$11.2M | ﹤0.01% | 623 |
|